A phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2+ metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Rugo, H. S.; Franco, S.; Munster, P.; Stopeck, A.; Ma, W.; Lyandres, J.; Lahiri, S.; Arbushites, M.; Koehler, M.; Dickler, M. N. |
| Abstract Title: | A phase II evaluation of lapatinib (L) and bevacizumab (B) in HER2+ metastatic breast cancer (MBC) |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 51s |
| Language: | English |
| ACCESSION: | WOS:000208457400247 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2008.26.15_suppl.1042 |
| Notes: | Meeting Abstract: 1042 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
